Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.

ASX company news and announcements for Imugene Limited (IMU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imugene Limited (IMU) ASX ...

The ASX200 has been up 0.5% at 8,582 points. The Aussie index pared early gains as speculation continues to swirl around the ...

Immunic (IMUX) announced that IMU-856, an orally available and systemically acting small molecule modulator that targets SIRT6, demonstrated a ...

Imugene Ltd (ASX:IMU) (OTCMKTS:IUGNF) is a clinical-stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to ...

Upcoming dividends for Imugene Limited (IMU) are announced to the ASX several weeks before the ex-dividend date. To be a paid a dividend, you must own shares in Imugene Limited (IMU) before the ...

The ASX200 has been up 0.5% at 8,582 points. The Aussie index pared early gains as speculation continues to swirl around the RBA’s rate decision due next week. IT and Staples have been the best ...